Menu Search
Equities

Chemed Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
CHE*:MEX

Chemed Corp

Actions
  • Price (MXN)9,083.33
  • Today's Change0.00 / 0.00%
  • Shares traded294.00
  • 1 Year change--
  • Beta0.4368
Data delayed at least 20 minutes, as of Jun 30 2025 12:30 BST.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company's segment includes VITAS and the Roto-Rooter. The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. The Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. The Company's water restoration services involve the remediation of water and humidity after a flood and are provided to both commercial and residential customers.

  • Revenue in USD (TTM)2.53bn
  • Net income in USD278.81m
  • Incorporated1970
  • Employees15.70k
  • Location
    Chemed Corp255 E. Fifth Street,, Suite 2600,CINCINNATI 45202United StatesUSA
  • Phone+1 (513) 762-6690
  • Fax+1 (302) 636-5454
  • Websitehttps://www.chemed.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.